Biomanufacturing, Supply Chain & Logistics
/--/uploads/sites/4/2025/05/d5a9b33b80b48c451dfac8a5d36316605736be55.png)
/--/uploads/sites/4/2025/12/life-science.jpg)
The region offers a diversified biomanufacturing ecosystem, covering multiple technological platforms for the production of biologics — including monoclonal antibodies and nanobodies, DNA plasmids, viral vectors, mRNA, and cell therapies. This broad range of CDMO services supports companies from early-stage development to large-scale commercial production.
/--/uploads/sites/4/2025/12/life-science.jpg)
A Strategic Logistics Hub in the Heart of Europe
Ideally located next to Brussels, Wallonia sits at the geographical heart of the European market, providing direct access to 500 million consumers, with 80% of Europe’s purchasing power within a 500-mile radius.
The region benefits from high-quality multimodal transport networks — road, rail, air, and waterway — ensuring efficient, temperature-controlled distribution of pharmaceuticals, biologics, and medical technologies across Europe and beyond.
World-class options for international pharma logistics
/--/uploads/sites/4/2025/12/life-science.jpg)
Trusted by Global Industry Leaders
Several global biopharma and medtech companies have chosen Wallonia for their strategic logistics and manufacturing operations, including: GSK, which operates Belgium’s largest biopharmaceutical logistics hub; Takeda, with its new state-of-the-art global warehouse; as well as Johnson & Johnson, Baxter, Mölnlycke, and Q1 Scientific.
Together, they reinforce Wallonia’s position as a European powerhouse for high-value supply chains and biomanufacturing excellence — combining innovation, reliability, and connectivity to deliver life-saving products worldwide.